PATENT CLAIM ANALYSIS

Application Number: 15772995
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "265100"]

Abstract:
The present invention relates to a 7-(thiazol-5-yl)pyrrolopyrimidine compound as a TLR7 agonist, and particularly relates to a compound shown in formula (I), pharmaceutically acceptable salt and preparation method thereof, a pharmaceutical composition containing such a compound, and usage thereof in preparing an antiviral drug.

Claim (Index 10):
The method according to  claim 9 , wherein the viral infection is viral infection of dengue fever virus, yellow fever virus, west nile virus, Japanese encephalitis virus, tick borne encephalitis virus, Kunjin virus, Murray Valley encephalitis virus, St Louis encephalitis virus, Omsk Hemorrhagic Fever virus, bovine viral diarrhea virus, Zika virus, or hepatitis virus.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15955523', '15503977', '15378576', '12383071', '16075303']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7471044937762281
- 35 USC 102 Novelty (BERT): 0.5334642335206506
- Combined Prediction Score: 0.7257404677506704
- Mean Citation Score: 280.63278
- Max Citation Score: 334.58817
- Similarity Product: 239.95199106934368

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test